Precision Biosciences (DTIL) Receivables - Net (2018 - 2026)
Precision Biosciences (DTIL) reported Receivables - Net of $4.0 million for Q1 2026, up 99900.0% year-over-year from N/an in Q1 2025, and up 99900.0% quarter-over-quarter from $4000.0 in Q3 2025.
Precision Biosciences (DTIL) Receivables - Net (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Receivables - Net data on file, last reported at $4.0 million in Q1 2026.
- Receivables - Net for Q1 2026 came in at $4.0 million, up 99900.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 million (up 99900.0% YoY), and the FY2024 annual result was $229000.0, down 74.58% from the prior year.
- Receivables - Net grew to $4.0 million in Q1 2026 per DTIL's latest filing, from $4000.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $50.5 million in Q2 2022 and troughed at $4000.0 in Q1 2025.
- A 5-year average of $4.2 million and a median of $652000.0 in 2023 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2025 and 2026: Receivables - Net tumbled 98.97% in 2025, then surged 99900.0% in 2026.
- A 5-year view of Receivables - Net shows it stood at $720000.0 in 2022, then grew by 25.14% to $901000.0 in 2023, then tumbled by 74.58% to $229000.0 in 2024, then slumped by 98.25% to $4000.0 in 2025, then surged by 99900.0% to $4.0 million in 2026.
- Business Quant data shows DTIL's Receivables - Net at $4.0 million in Q1 2026, $4000.0 in Q3 2025, and $4000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 229,000.00 |
| Dec 31, 2024 | 229,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 207,000.00 |
| Jun 30, 2024 | 207,000.00 |
| Mar 31, 2024 | 390,000.00 |
| Mar 31, 2024 | 390,000.00 |
| Dec 31, 2023 | 901,000.00 |
| Dec 31, 2023 | 901,000.00 |
| Sep 30, 2023 | 3.51 Mn |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 652,000.00 |
| Jun 30, 2023 | 652,000.00 |